China Pharma Holdings, Inc. is a pioneering company in the healthcare sector, developing and manufacturing innovative pharmaceutical products to combat high-incidence and high-mortality diseases, with a strong focus on the Chinese market.

China Pharma Holdings, Inc. is a pharmaceutical company based in China that develops and manufactures products for high-incidence and high-mortality diseases, primarily marketed within the Chinese healthcare market.

China Pharma Holdings, Inc. has experienced fluctuations in its stock performance, with a recent close price of $1.83, amidst its focus on developing pharmaceutical products for high-incidence diseases in China.

China Pharma Holdings, Inc. has experienced fluctuations in its stock performance, with a 52-week high of $3.40 and a 52-week low of $1.20, as of June 12, 2025.

The global pharmaceutical industry is experiencing a surge in international interest, with China Pharma Holdings Inc. poised to benefit from the positive trends in global pharma trade.